Ling Xu
20Patents
5h-index
59Co-inventors
72Inventor score
Filing activity: Oct 11, 2000 → Mar 13, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8454972B2 | Method for inducing a multiclade immune response against HIV utilizing a multigene and multiclade immunogen | Chemistry; Metallurgy | 46 | Active |
| US6723349B1 | Polyoxometalate materials, metal-containing materials, and methods of use thereof | Emerging Cross-Sectional Technologies | 30 | Expired |
| US7097858B2 | Polyoxometalate materials, metal-containing materials, and methods of use thereof | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6713076B1 | Methods for removing a contaminant by a polyoxometalate-modified fabric or a polyoxometalate-modified cellulosic fiber and fabrics thereof | Textiles; Paper | 6 | Expired |
| US11129905B2 | Bivalent, bispecific binding proteins for prevention or treatment of HIV infection | Chemistry; Metallurgy | 5 | Active |
| US11186649B2 | Anti-CD38 antibodies and methods of use | Chemistry; Metallurgy | 5 | Active |
| US11530268B2 | Trispecific anti-CD38, anti-CD28, and anti-CD3 binding proteins and methods of use for treating viral infection | Chemistry; Metallurgy | 3 | Active |
| US7638318B2 | Seneca Valley virus based compositions and methods for treating disease | Physics | 3 | Active |
| US8039606B2 | Seneca Valley virus based compositions and methods for treating disease | Chemistry; Metallurgy | 2 | Active |
| US11779651B2 | Bivalent, bispecific binding proteins for prevention or treatment of HIV infection | Chemistry; Metallurgy | 2 | Active |
| US8753622B2 | Seneca valley virus based compositions and methods for treating disease | Physics | 1 | Active |
| US11613576B2 | Trispecific binding proteins, methods, and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US8268323B2 | Conformationally stabilized HIV envelope immunogens | Chemistry; Metallurgy | 1 | Active |
| US11059762B2 | Selective hydrogenation methods | Emerging Cross-Sectional Technologies | 0 | Active |
| US8715686B2 | Conformationally stabilized HIV envelope immunogens | Chemistry; Metallurgy | 0 | Active |
| US11623902B2 | Selective hydrogenation methods and catalysts | Emerging Cross-Sectional Technologies | 0 | Active |
| US8044185B2 | Conformationally stabilized HIV envelope immunogens and triggering HIV-I envelope to reveal cryptic V3-loop epitopes | Chemistry; Metallurgy | 0 | Active |
| US12227573B2 | Trispecific binding proteins, methods, and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12156870B2 | Antibody drug conjugates comprising sting agonists | Chemistry; Metallurgy | 0 | Active |
| US11634370B2 | Selective hydrogenation methods | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.